PubRank

D Boraschi

Author PubWeight™ 86.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Regulation of the macrophage content of neoplasms by chemoattractants. Science 1983 1.83
2 Natural and antibody-dependent cell-mediated activity against Salmonella typhimurium by peripheral and intestinal lymphoid cells in mice. J Immunol 1983 1.82
3 Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res 1990 1.77
4 Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production. J Immunol 1984 1.75
5 Natural killer activity of gut mucosal lymphoid cells in mice. Eur J Immunol 1981 1.73
6 Morphological characterization of a cell population responsible for natural killer activity. Immunology 1981 1.73
7 Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA. Nature 1984 1.71
8 Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice. J Immunol 1979 1.48
9 Macrophage activation for tumor cytotoxicity: analysis of intermediary reactions. J Reticuloendothel Soc 1979 1.31
10 A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity. J Immunol 1986 1.30
11 IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine. J Immunol 1986 1.30
12 IgA-dependent cell-mediated activity against enteropathogenic bacteria: distribution, specificity, and characterization of the effector cells. J Immunol 1984 1.24
13 The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J Immunol 1998 1.24
14 Regulation of arachidonic acid metabolism in macrophages by immune and nonimmune interferons. J Immunol 1985 1.17
15 In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta. J Immunol 1987 1.16
16 Natural anti-bacterial activity against Salmonella typhi by human T4+ lymphocytes armed with IgA antibodies. J Immunol 1985 1.16
17 Cellular immunity against Salmonella typhi after live oral vaccine. Clin Exp Immunol 1985 1.15
18 Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1. Blood 1992 1.12
19 Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains. Cell Immunol 1979 1.11
20 Effects of in vivo treatments with cyclosporin-A on mouse cell-mediated immune responses. Int J Immunopharmacol 1981 1.08
21 Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli. J Immunol 1979 1.07
22 Differential binding of IL-1 alpha and IL-1 beta to receptors on B and T cells. FEBS Lett 1989 1.05
23 Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1beta/IL-1R(I) complex. FEBS Lett 2001 1.05
24 In vitro generated mast cells express natural cytotoxicity against tumour cells. Immunology 1985 1.05
25 IFN-beta-induced reduction of superoxide anion generation by macrophages. Immunology 1982 1.04
26 Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines. Eur J Immunol 1981 1.04
27 Role of metalloproteases in the release of the IL-1 type II decoy receptor. J Biol Chem 1997 1.02
28 Defective tumoricidal capacity of macrophages from A/J mice. III. Genetic analysis of the macrophage defect. J Immunol 1980 1.02
29 Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness. J Immunol 1980 1.02
30 Interferon inhibits prostaglandin biosynthesis in macrophages: effects on arachidonic acid metabolism. J Immunol 1984 1.02
31 Correlation between the lipopolysaccharide response of mice and the capacity of mouse peritoneal cells to transfer an antiviral state. Role of endogenous interferon. J Immunol 1987 1.01
32 Immunoreactivity for IL-1 beta and TNF alpha in human lymphoid and nonlymphoid tissues. Am J Pathol 1989 1.01
33 Enhancement of in vivo immune response by tumor necrosis factor. J Immunol 1987 1.00
34 Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study. Am J Pathol 1990 1.00
35 Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: evidence for a role in the regulation of the macrophage content of neoplastic tissues. Int J Cancer 1983 0.99
36 In vivo restoration of T cell functions by human IL-1 beta or its 163-171 nonapeptide in immunodepressed mice. J Immunol 1988 0.98
37 Cyclooxygenase-2 and synthesis of PGE2 in human bronchial smooth-muscle cells. Am J Respir Crit Care Med 1997 0.96
38 Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli. J Immunol 1980 0.96
39 Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity. Immunology 1983 0.93
40 Modulation of macrophage suppressive activity and prostaglandin release by lymphokines and interferon: comparison of alveolar, pleural and peritoneal macrophages. Clin Exp Immunol 1984 0.93
41 The membrane form of the type II IL-1 receptor accounts for inhibitory function. J Immunol 2000 0.93
42 Genetic control of in vitro natural cell-mediated activity against Salmonella typhimurium by intestinal and splenic lymphoid cells in mice. Clin Exp Immunol 1984 0.92
43 Cytokine-associated tissue injury and lethality in mice: a comparative study. Clin Immunol Immunopathol 1991 0.90
44 Comparative analysis of immunological responses to oral (Ty21a) and parenteral (TAB) typhoid vaccines. Infect Immun 1988 0.89
45 Effect of carrier priming on antibody avidity in the in vivo and in vitro immune response. Immunology 1977 0.88
46 Interferons inhibit LTC4 production in murine macrophages. J Immunol 1987 0.86
47 Regulation of macrophage suppression and cytotoxicity by interferon role of Ia-bearing macrophages. J Immunol 1982 0.85
48 Development of cell-mediated antiviral immunity and macrophage activation in C3H/HeN mice infected with mouse mammary tumor virus. J Immunol 1980 0.85
49 Lymphocytes from autoimmune MRL lpr/lpr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain. J Immunol 2001 0.85
50 Binding of IL-1 beta to IL-1R type II at single cell level. J Immunol 1991 0.84
51 Natural antibacterial activity against Salmonella typhi in human cord blood. J Immunol 1989 0.84
52 Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria. Cytokine 2013 0.84
53 IgA-driven antibacterial activity against Streptococcus pneumoniae by mouse lung lymphocytes. Am Rev Respir Dis 1988 0.83
54 Identification of MIP-1 alpha/LD78 as a monocyte chemoattractant released by the HTLV-I-transformed cell line MT4. AIDS Res Hum Retroviruses 1995 0.82
55 Single-cell analysis of macrophage chemotactic protein-1-regulated cytosolic Ca2+ increase in human adherent monocytes. Blood 1995 0.81
56 Lymphokine-activated tumor inhibition in mice. Ability of a nonapeptide of the human IL-1 beta to recruit anti-tumor reactivity in recipient mice. J Immunol 1989 0.81
57 Macrophage activation by interferon: dissociation between tumoricidal capacity and suppressive activity. Eur J Immunol 1982 0.81
58 Interleukin-1 beta primes interleukin-8-stimulated chemotaxis and elastase release in human neutrophils via its type I receptor. Eur Cytokine Netw 1997 0.81
59 Functional epitope mapping of human interleukin-1 beta by surface plasmon resonance. Eur Cytokine Netw 1997 0.81
60 Macrophages and interdigitating reticulum cells in normal human thymus and thymomas: immunoreactivity for interleukin-1 alpha, interleukin-1 beta and tumour necrosis factor alpha. Histopathology 1990 0.80
61 Mapping of biologically relevant sites on human IL-1 beta using monoclonal antibodies. J Immunol 1988 0.80
62 Type II interleukin-1 receptor is not expressed in cultured endothelial cells and is not involved in endothelial cell activation. Blood 1993 0.80
63 Purification of human recombinant interleukin 1 receptor antagonist proteins upon Bacillus subtilis sporulation. Protein Expr Purif 1997 0.79
64 Interleukin-1 beta induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti-tumor effects of tumor necrosis factor alpha or beta. Int J Cancer 1989 0.79
65 Immunohistochemical localization of IL-1 alpha and IL-1 beta in normal human placenta. Lymphokine Cytokine Res 1991 0.79
66 Peyer's patch lymphocytes express natural cytotoxicity but not natural killer activity. Nat Immun Cell Growth Regul 1984 0.79
67 Interleukin 1 stimulates production of LTC4 and other eicosanoids by macrophages. Lymphokine Res 1989 0.78
68 Quantitation of biologically active IL-1 by a sensitive assay based on immobilized human IL-1 receptor type II (IL-1RII). J Immunol Methods 1991 0.78
69 Dissociation between macrophage tumoricidal capacity and suppressive activity: analysis with macrophage-defective mouse strains. J Immunol 1983 0.78
70 Cytokines as vaccine adjuvants: interleukin 1 and its synthetic peptide 163-171. Vaccine 1993 0.78
71 Murine interferon-gamma/interleukin-1 fusion proteins used as antigens for the generation of hybridomas producing monoclonal anti-interleukin-1 antibodies. Cytokine 1991 0.78
72 IL-1 receptor subtypes possess distinct binding properties for IL-1 alpha and IL-1 beta. Prog Clin Biol Res 1990 0.78
73 Macrophage antitumor activity: impaired responsiveness to interferon-gamma of macrophages from genetically defective mice. Eur J Immunol 1984 0.78
74 Modulation of in vitro natural cell-mediated activity against enteropathogenic bacteria by simple sugars. Infect Immun 1985 0.78
75 One-step immunoaffinity purification of bioactive human recombinant IL-1 beta with a monoclonal antibody directed to a well-exposed domain of the protein. J Immunol Methods 1989 0.77
76 Comparison of human interleukin-1 beta and its 163-171 peptide in bone resorption and the immune response. Cytokine 1991 0.77
77 Natural antiviral activity of mouse macrophages against encephalomyocarditis virus. Antiviral Res 1985 0.77
78 Antibacterial resistance induced by recombinant interleukin 1 in myelosuppressed mice: effect of treatment schedule and correlation with colony-stimulating activity in the bloodstream. Cell Immunol 1990 0.77
79 Defining agonist peptides of human interleukin-1 beta. Lymphokine Res 1989 0.77
80 Balance between autocrine interleukin-1beta and caspases defines life versus death of polymorphonuclear cells. Eur Cytokine Netw 2001 0.77
81 Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II. J Immunol 1997 0.77
82 Adjuvant activity of the 163-171 peptide of human IL-1 beta administered through different routes. Lymphokine Res 1987 0.77
83 Metabolic behavior and distribution of the synthetic nonapeptide fragment 163-171 of human IL-1 beta. Lymphokine Res 1990 0.77
84 Challenges in the design of clinically useful brain-targeted drug nanocarriers. Curr Med Chem 2014 0.76
85 Sporulation: an alternative way to recover recombinant proteins from Bacillus subtilis. Biotechnol Bioeng 1995 0.76
86 Effects of intraperitoneal recombinant interleukin-1 beta in intraperitoneal human ovarian cancer xenograft models: comparison with the effects of tumour necrosis factor. Br J Cancer 1992 0.76
87 Effects of whole-body irradiation on antibody affinity. Immunology 1977 0.75
88 Effect of the age-related immune depression induced by MTV on the in vivo growth of a mammary carcinoma. Br J Cancer 1981 0.75
89 Anti-inflammatory activity of IFN-beta in carrageenan-induced pleurisy in the mouse. Clin Exp Immunol 1986 0.75
90 Genetic aspects of macrophage activation for tumor cytotoxicity. Adv Exp Med Biol 1982 0.75
91 Radiolabeling of the biologically active peptide 163-171 of human interleukin-1 beta. Int J Rad Appl Instrum A 1990 0.75
92 Regulation of macrophage functions by interferon. Adv Exp Med Biol 1982 0.75
93 Lymphokine-activated tumor inhibition: combinatory activity of a synthetic nonapeptide from interleukin-1, interleukin-2, interleukin-4, and interferon-gamma injected around tumor-draining lymph nodes. Int J Cancer Suppl 1989 0.75
94 Different conformation of purified human recombinant interleukin 1 beta from Escherichia coli and Saccharomyces cerevisiae is related to different level of biological activity. Biochem Biophys Res Commun 1989 0.75
95 Symposium: The role of macrophages in tumor immunology. J Reticuloendothel Soc 1979 0.75
96 A short synthetic peptide fragment of human interleukin-1 beta increases both human and murine natural killer activity. Nat Immun Cell Growth Regul 1989 0.75
97 T cell independent induction of antigen specific suppression of the antibody response. Ric Clin Lab 1980 0.75
98 Species-restricted effects of human and mouse lymphokines on macrophages. Eur J Immunol 1980 0.75
99 Antibacterial activity of lymphocytes armed with IgA. Adv Exp Med Biol 1987 0.75
100 Influence of the peptide insolubilization method on detection of anti-peptide antibodies in ELISA. Evaluation of nonspecific interactions. J Immunoassay 1989 0.75
101 Local and systemic immunity after typhoid vaccines. Ann Sclavo Collana Monogr 1986 0.75
102 IL-18 and IL-18 receptors in the development of autoimmunity. Eur Cytokine Netw 2000 0.75
103 Neutrophil apoptosis in autoimmune Fas-defective MRL lpr/lpr mice. Eur Cytokine Netw 2001 0.75
104 Antibacterial activity against Streptococcus pneumoniae by mouse lung lymphocytes. Adv Exp Med Biol 1987 0.75
105 Cellular immunity against Salmonella typhi after live oral vaccine. Adv Exp Med Biol 1987 0.75
106 Interaction between interleukin-1 and ciliary neurotrophic factor in the regulation of neuroblastoma cell functions. Eur Cytokine Netw 1997 0.75
107 Macrophage antitumor activity in vitro. Comparative analysis of cytolytic, cytostatic, and cytotoxic activities of mouse macrophages and human monocytes. Immunobiology 1984 0.75
108 Non-inflammatory peptide fragments of IL1 as safe new-generation adjuvants. Res Immunol 1992 0.75
109 Lymphocyte activating factor activity in the serum and cerebrospinal fluid of patients with multiple sclerosis. Ital J Neurol Sci 1990 0.75
110 Radiation protection and restoration by the synthetic 163-171 nonapeptide of human interleukin 1 beta. Radiat Res 1991 0.75